{
    "clinical_study": {
        "@rank": "159590", 
        "arm_group": {
            "arm_group_label": "genexolPM + cisplatin", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This clinical trial is Phase II trial for evaluating efficacy of induction chemotherapy\n      using Genexol-PM + cisplatin for locally advanced head and neck cancer. The investigators\n      try to evaluate response rate of Genexol-PM + cisplatin chemotherapy, and safety profile."
        }, 
        "brief_title": "Efficacy Study of Genexol-PM and Cisplatin in Locally Advanced Head and Neck Cancer", 
        "completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Locally Advanced Head and Neck Squamous Cell Carcinoma", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Squamous Cell", 
                "Head and Neck Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  locally advanced head and neck squamous cell carcinoma\n\n          -  oral cavity, oropharynx, hypopharynx, larynx\n\n          -  measurable lesion\n\n          -  unresectable\n\n          -  age 18 or more\n\n          -  ECOG 0 or 1\n\n        Exclusion Criteria:\n\n          -  distant metastasis\n\n          -  pregnancy\n\n          -  prior chemotherapy or radiation therapy\n\n          -  2ndary malignancy\n\n          -  other unfit medical condition"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "53", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 30, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01689194", 
            "org_study_id": "CRCST-L-0007", 
            "secondary_id": "H-1204-103-407"
        }, 
        "intervention": {
            "arm_group_label": "genexolPM + cisplatin", 
            "intervention_name": "genexolPM + cisplatin", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Cisplatin"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 23, 2014", 
        "location": [
            {
                "contact": {
                    "email": "bhumsuk@snu.ac.kr", 
                    "last_name": "Bhumsuk Keam, MD", 
                    "phone": "82-2-2072-7215"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "110-744"
                    }, 
                    "name": "Seoul National University Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Seoul National University Hospital"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase II Study of Genexol-PM and Cisplatin as Induction Chemotherapy in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)", 
        "overall_contact": {
            "email": "bhumsuk@snu.ac.kr", 
            "last_name": "Bhumsuk Keam, MD", 
            "phone": "82-2-2072-7215"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University Hospital", 
            "last_name": "Se-Hoon Lee, MD PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "RECIST", 
            "measure": "response rate", 
            "safety_issue": "No", 
            "time_frame": "every 2 cycles, 6wk later after chemotherapy"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01689194"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Se-Hoon Lee", 
            "investigator_title": "professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "NCI CTCAE", 
                "measure": "Locoregional control rate", 
                "safety_issue": "No", 
                "time_frame": "every 3wk (every cycle)"
            }, 
            {
                "description": "EORTC Q30", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "every 3wk (every cycle)"
            }, 
            {
                "description": "NCI CTCAE v3.0 Neutropenia, leucopenia, thrombocytopenia, hepatotoxicity, renal toxicity", 
                "measure": "safety", 
                "safety_issue": "Yes", 
                "time_frame": "every 3wk (every cycle)"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "Clinical Research Center for Solid Tumor, Korea", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}